Cintas (CTAS) Short-term Investments (2017 - 2018)
Quarterly results put Short-term Investments at $33.7 million for Q1 2018, changed N/A from a year ago — trailing twelve months through Feb 2018 was $33.7 million (changed N/A YoY), and the annual figure for FY2017 was $22.2 million, changed.
Cintas has reported Short-term Investments over the past 7 years, most recently at $33.7 million for Q1 2018.
- Short-term Investments reached $33.7 million in Q1 2018 per CTAS's latest filing, up from $22.7 million in the prior quarter.
- Across five years, Short-term Investments topped out at $33.7 million in Q1 2018 and bottomed at $4.8 million in Q1 2014.
- Median Short-term Investments over the past 3 years was $22.2 million (2017), compared with a mean of $21.0 million.
- Peak annual rise in Short-term Investments hit 82.85% in 2014, while the deepest fall reached 82.85% in 2014.
- Over 3 years, Short-term Investments stood at $4.8 million in 2014, then soared by 369.67% to $22.7 million in 2017, then soared by 48.22% to $33.7 million in 2018.
- Business Quant data shows Short-term Investments for CTAS at $33.7 million in Q1 2018, $22.7 million in Q4 2017, and $21.6 million in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2018 | 33.69 Mn |
| Nov 30, 2017 | 22.73 Mn |
| Aug 31, 2017 | 21.63 Mn |
| May 31, 2017 | 22.22 Mn |